UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000039482
Receipt number R000045019
Scientific Title A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease
Date of disclosure of the study information 2020/02/14
Last modified on 2024/02/06 09:36:11

No. Disposal Last modified on Item of update
1 Insert 2020/02/14 14:36:22
2 Update 2020/05/22 18:45:41 Institutions
3 Update 2020/06/10 13:20:27 Institutions
4 Update 2020/10/16 16:28:32 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
5 Update 2020/10/16 16:39:17 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
6 Update 2020/10/16 16:42:15 Last follow-up date
7 Update 2021/05/20 17:47:00 Key inclusion criteria
Key inclusion criteria
Target sample size
8 Update 2021/05/20 17:48:09 Last follow-up date
9 Update 2021/05/24 18:25:22 Institutions
10 Update 2024/02/05 11:36:09 Last follow-up date
Date of closure to data entry
Date analysis concluded
11 Update 2024/02/05 11:51:09 Recruitment status
12 Update 2024/02/06 09:36:11 Number of participants that the trial has enrolled